Related Experiment Videos
High-dose-rate intraluminal brachytherapy for bile duct carcinoma after surgery
K Kurisu1, Y Hishikawa, M Taniguchi
1Department of Radiology, Hyogo College of Medicine, Japan.
Abstract:
Five patients with recurrent or residual bile duct carcinoma after surgery were treated with high-dose-rate intraluminal brachytherapy (HDRIBT) using a remote afterloader. External radiotherapy was also given in three cases. HDRIBT is considered to be an effective mode of radiotherapy for residual or recurrent bile duct tumors.